...

Bruker Welcomes Thierry Bernard to its Board of Directors

Bruker Announces Appointment of Thierry Bernard

Bruker Corporation recently announced the appointment of Mr. Thierry L. Bernard to its Board of Directors. The appointment is effective immediately. Mr. Bernard is a prominent executive in the international life-science tools and diagnostics industry. He brings decades of strategic and operational leadership experience to the company.

Currently, Mr. Bernard serves as the Chief Executive Officer of QIAGEN N.V. He joined that firm in 2015 and became CEO in 2019. He previously spent 15 years with bioMérieux SA in various senior leadership roles. These included serving as Corporate Vice President for Global Commercial Operations and Investor Relations.

Strengthening Strategic Leadership and Expertise

The addition of Mr. Bernard to the Board of Directors supports Bruker’s goal of profitable growth. The company aims for rapid margin expansion and enhanced stakeholder value in the post-genomic era. Bruker specializes in high-performance scientific instruments and analytical solutions for life science research and diagnostics.

“Bruker is delighted that Thierry is joining our Board,” said Frank H. Laukien, Chairman, President, and CEO of Bruker Corporation. “I have admired his successful track record for many years. I am convinced that Thierry will be an excellent addition to our Board of Directors as we further develop our leadership position in life-science research.”

Mr. Bernard also serves as the Chair of the Board for the trade association AdvaMedDx. He holds degrees from several prestigious institutions, including Harvard Business School and the London School of Economics.

“I am very pleased to join Bruker’s Board of Directors,” said Thierry Bernard. “I have long admired its significant contributions to scientific research and improving patient outcomes. I look forward to supporting its continued development and commitment to long-term value creation.”

Bruker continues to enable scientists to explore life at the molecular and cellular levels. Its technologies support precise diagnostics and effective therapies across the global healthcare landscape.

Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.

News Source: Businesswire.com